Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rubinstein

Showing results (241-250 of 558) with videos related to

Pageof 56
Sort By:
Lancet (London, England)|April 6, 1985
Ocular toxicity of desferrioxamineM Rubinstein, P Dupont, J P Doppee, et al.
Brain Research|December 11, 1989
Neurochemical and behavioral correlates of unilateral striatal acetylcholinesterase inhibition by fasciculin in ratsB Bolioli, M E Castelló, D Jerusalinsky, et al.
Fertility and Sterility|April 9, 1998
Pregnancy after human donor oocyte cryopreservation and thawing in association with intracytoplasmic sperm injection in a patient with ovarian failureE Polak de Fried, J Notrica, M Rubinstein, et al.
Journal of Cellular and Molecular Medicine|November 30, 2013
Induction of heparanase by HPV E6 oncogene in head and neck squamous cell carcinomaNir Hirshoren, Raanan Bulvik, Tzahi Neuman, et al.
Journal of Medical Genetics|December 1, 1980
A family segregating for E1j and E1k at cholinesterase locus 1R T Evans, J Iqbal, A A Dietz, et al.
Biomedicines|March 29, 2023
Radiation-Induced Nephropathy in the Murine Model Is Ameliorated by Targeting HeparanaseAlexia Abecassis, Esther Hermano, Kim Sheva, et al.
The EMBO Journal|September 2, 1998
Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNTE Zelzer, Y Levy, C Kahana, et al.
Annals of Hematology|October 17, 2024
Novel use of Siltuximab in a patient with VEXAS SyndromeBeatriz Cáceres-Nazario, Joshua Rivenbark, Manish K Saha, et al.
The Annals of Applied Statistics|August 6, 2024
BUILDING A DOSE TOXO-EQUIVALENCE MODEL FROM A BAYESIAN META-ANALYSIS OF PUBLISHED CLINICAL TRIALSElizabeth A Sigworth, Samuel M Rubinstein, Jeremy L Warner, et al.
Neuroreport|November 26, 1999
D3 receptor knockdown through antisense oligonucleotide administration supports its inhibitory role in locomotionL B Menalled, G Dziewczapolski, M C Garcia, et al.
Pageof 56

Showing results (241-250 of 558) with videos related to

Sort By:
Pageof 56
Lancet (London, England)|April 6, 1985
Ocular toxicity of desferrioxamineM Rubinstein, P Dupont, J P Doppee, et al.
Brain Research|December 11, 1989
Neurochemical and behavioral correlates of unilateral striatal acetylcholinesterase inhibition by fasciculin in ratsB Bolioli, M E Castelló, D Jerusalinsky, et al.
Fertility and Sterility|April 9, 1998
Pregnancy after human donor oocyte cryopreservation and thawing in association with intracytoplasmic sperm injection in a patient with ovarian failureE Polak de Fried, J Notrica, M Rubinstein, et al.
Journal of Cellular and Molecular Medicine|November 30, 2013
Induction of heparanase by HPV E6 oncogene in head and neck squamous cell carcinomaNir Hirshoren, Raanan Bulvik, Tzahi Neuman, et al.
Journal of Medical Genetics|December 1, 1980
A family segregating for E1j and E1k at cholinesterase locus 1R T Evans, J Iqbal, A A Dietz, et al.
Biomedicines|March 29, 2023
Radiation-Induced Nephropathy in the Murine Model Is Ameliorated by Targeting HeparanaseAlexia Abecassis, Esther Hermano, Kim Sheva, et al.
The EMBO Journal|September 2, 1998
Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNTE Zelzer, Y Levy, C Kahana, et al.
Annals of Hematology|October 17, 2024
Novel use of Siltuximab in a patient with VEXAS SyndromeBeatriz Cáceres-Nazario, Joshua Rivenbark, Manish K Saha, et al.
The Annals of Applied Statistics|August 6, 2024
BUILDING A DOSE TOXO-EQUIVALENCE MODEL FROM A BAYESIAN META-ANALYSIS OF PUBLISHED CLINICAL TRIALSElizabeth A Sigworth, Samuel M Rubinstein, Jeremy L Warner, et al.
Neuroreport|November 26, 1999
D3 receptor knockdown through antisense oligonucleotide administration supports its inhibitory role in locomotionL B Menalled, G Dziewczapolski, M C Garcia, et al.
Pageof 56